...
首页> 外文期刊>Trends in Cardiovascular Medicine >MicroRNAs and Aneurysm Formation
【24h】

MicroRNAs and Aneurysm Formation

机译:微小RNA与动脉瘤形成

获取原文
获取原文并翻译 | 示例
           

摘要

Aneurysms occur in large arteries and are characterized by pathological widening of the vessel and thinning of the vessel wall. In the past decade, microRNAs (miRs) have emerged as key regulators of biological processes, and they were recently shown to be involved in aneurysm formation. A few miRs have been proposed to play a role in aneurysm development, such as miR-21, miR-26, and miR-143/145. Several recent studies describe the involvement of miR-29 in aneurysm formation by post-transcriptionally repressing the expression of extracellular matrix proteins. Therapeutic inhibition of miR-29 using anti-miRs attenuates experimental aneurysm formation in mice. This review provides an overview of the upstream regulation of miR-29 as well as the downstream targets of miR-29. It also discusses the potential clinical use for miR-29 inhibitors and the role of other miRs involved in aneurysm formation.
机译:动脉瘤发生在大动脉中,其特征在于血管的病理性增宽和血管壁变薄。在过去的十年中,microRNA(miRs)已成为生物过程的关键调节因子,最近已证明它们参与了动脉瘤的形成。已经提出了一些miR在动脉瘤的形成中起作用,例如miR-21,miR-26和miR-143 / 145。最近的一些研究描述了miR-29通过转录后抑制细胞外基质蛋白的表达参与动脉瘤的形成。使用抗miRs对miR-29进行治疗性抑制可减弱小鼠实验性动脉瘤的形成。这篇综述概述了miR-29的上游调控以及miR-29的下游靶标。它还讨论了miR-29抑制剂的潜在临床用途以及其他miR在动脉瘤形成中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号